Clinical trials

#Biologics / Biotechnology #Clinical trials #Manufacturing #Pharma

This week in drug discovery (2-6 May)   

Swiss biotech sector sees strong performance in 2021, report says  Switzerland’s life sciences sector saw a strong year in 2021 with companies contributing to the Covid-19 pandemic and high levels of capital investments being key indicators of the sector’s strength.   This is according to the… Read More

#News

#Clinical trials #IBD #Precision medicine

Iterative Scopes expands IBD offering with acquisitions  

Precision medicine technologies company Iterative Scopes has acquired two clinical trial optimisation companies focused on streamlining and accelerating the drug development process for inflammatory bowel disease (IBD).  The company has acquired Clinical Research Strategy Group, LLC and Precision Research (CRSG/Precision) in an effort to bolster its efforts… Read More

#News

#AI #Biotechnology #Clinical trials #mRNA

Talking tech in 2022

Listen to this article on the DDW Podcast: With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. With Q1 on its way out, Lu Rahman highlights the technology… Read More

#Exclusive Content

#Clinical trials #Drug delivery

ISA Pharmaceuticals cancer trial using drug delivery technology  

Biotech ISA Pharmaceuticals has launched a clinical trial using its Amplivant adjuvant technology which will enable the delivery of a cancer vaccine in patients.  The clinical trial, run by partner Scancell Holdings, is a multicentre clinical trial testing Scancell’s Modi-1 vaccine in patients with triple negative… Read More

#News

#Clinical trials #Decentralised clinical trials #Queen’s Award

Medical Research Network wins Queen’s Award for clinical trials 

Clinical trial support organisation Medical Research Network (MRN) has won a Queen’s Award for Enterprise for International Trade for its work in helping enhance the delivery of clinical trials through decentralisation technology.  The Queen’s Awards   Established in 1965, The Queen’s Awards for Enterprise are the… Read More

#News

#Clinical trials #CRO #Emmes

Getting the right CRO team: culture is as important as skill set  

The CRO market has seen tremendous growth in the last 10 years, undergoing significant changes in terms of remote trials, smaller patient populations, as well as the more recent pandemic pressures.   The drug pipeline is also now larger than ever and CROs have increased their strategic importance… Read More

#News

#Clinical trials #Patient centricity

Calls for life sciences to focus on patient centricity  

The life sciences and healthcare industries should restructure around patient centricity, according to global not-for-profit the Pistoia Alliance.   The call follows a meeting at the Pistoia Alliance’s annual European conference in London where discussions around the sector’s position in the wake of the Covid-19 pandemic took place. Read More

#News

#Clinical trials #Covid-19 #Healthcare #HIV #Malaria #Public health

World Health Day: We celebrate global drug discovery

As we celebrate World Health Day, Lu Rahman looks at some of the key drug discovery and development successes over the last year that have significantly helped improved the health and wellbeing of the global population.   Malaria breakthroughs  According to The World Health Organization (WHO) more than a million people in Africa… Read More

#Editor's Choice #Exclusive Content #News

#Analysis #Clinical trials #Data #Research #Ukraine

How war in Ukraine impacts global clinical development 

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that… Read More

#News #Trending News

#Arthritis #Clinical trials #Covid-19 #Drug therapy

Covid-19 study boosts Swedish rheumatoid arthritis programme 

Cyxone, a Swedish clinical stage biotech company developing disease modifying therapies for diseases such as rheumatoid arthritis (RA), confirms the previously demonstrated favourable safety and tolerability profile for its drug candidate Rabeximod, in the Clinical Study Report from its exploratory Phase II study in Covid-19 patients.   Other… Read More

#News

#Clinical trials #Infectious diseases #Malaria

Landmark approval of child-friendly malaria treatment 

According to the Medicines for Malaria Venture (MMV),the Australian Therapeutic Goods Administration (TGA) has approved the use of single-dose Kozenis (tafenoquine) in children aged two years and above in combination with chloroquine for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria.  The approval… Read More

#News #Trending News

#Alzheimer's #Clinical trials #Pharma

Winterlight Labs launches speech assessment collaboration  

Digital biomarkers developer Winterlight Labs and memory clinic Alzheimer Center Amsterdam will work together on a project to decentralise assessments of patients’ cognition and function in the study of preclinical Alzheimer’s disease.   The project will see Alzheimer Center Amsterdam develop a remote measurement toolbox, integrating Winterlight’s digital… Read More

#News

#Clinical trials #Covid-19 #Healthcare #Public health

Interview: Delivering smart clinical trials for better health 

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the… Read More

#Covid-19 #Exclusive Content #News #Opinion

#Clinical trials #Sano Genetics

Sano Genetics raises $11m to expand patient recruitment tech  

Healthtech company Sano Genetics has raised $11 million in a Series A funding round to help it expand its patient recruitment technology.  Sano Genetics has developed a software platform that connects patients living with rare and chronic conditions with biotech and pharma companies leading personalised medicine research. Read More

#News

#Clinical trials #Research study

This week in drug discovery (21-25 March) 

News round-up by DDW’s Megan Thomas for 14-18 March, 2022  New breakthroughs, results, clinical trials and research exemplify the constant and forward-moving trajectory of the drug discovery and development industry in this week’s news round up.  1. Atrogi gets go-ahead to begin Phase I study… Read More

#News

Kidneys
#4D Pharma #Clinical trials

4D Pharma announces positive results for combination therapy  

4D Pharma has announced positive interim results for its Phase I/II study of a combination therapy targeting the treatment of renal cell carcinoma.   The company is investigating the combination of its lead immune-oncology single strain Live Biotherapeutic MRx0518 with Merck’s (MSD) anti-PD-1 therapy, KEYTRUDA(R) (pembrolizumab) in… Read More

#News